Longevity Health Holdings, Inc. XAGE

Q2 FY2026 · ended Jun 30, 2026 · Revenue $395,991, -21.4% YoY · Filed Aug 14, 2026

Longevity Health Holdings, Inc. (XAGE) files with the SEC under industry code 2840, Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $395,991 and a net loss of $1.9 million. As of Jun 30, 2026 it held $35,471 in cash and investments and $260,647 in total debt.

Revenue
$395,991
-21.4% vs year-ago quarter
Net income
$-1.88M
+0.2% vs year-ago quarter
Operating cash flow
$-223,881
+73.2% vs year-ago quarter
Free cash flow
$-306,368
+78.8% vs prior quarter
EPS
$-0.75
+50.7% vs year-ago quarter
Dividend per share
None
Shares outstanding
2.48M
+38.9% vs year-ago quarter
Net cash
$-225,176
Q2 FY2026
Operating margin
-343.6%
TTM

Company profile

Industry
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (SIC 2840)
Listed as
XAGE (OTC), XAGEW (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Pittsburgh, PA
SEC filer status
, Emerging growth company
SEC CIK
1842939
Former names
Carmell Corp (until Feb 13, 2025); ALPHA HEALTHCARE ACQUISITION CORP III (until Jul 20, 2023)

Other Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$395,991
$391,764
$472,982
$425,864
$503,612
Operating income
-$724,150
-$1.3M
-$2.3M
-$1.5M
-$1.9M
Net income
-$1.9M
-$1.4M
-$2.1M
-$1.4M
-$1.9M
Diluted EPS
—
-$0.75
-$1.17
-$0.83
-$1.56
Operating cash flow
-$223,881
-$485,291
-$306,367
-$1.4M
-$836,190
Free cash flow
—
—
-$306,368
-$1.4M
—
Total assets
$1.1M
$1.6M
$2.4M
$3.3M
$3.7M
Total liabilities
$9.8M
$8.5M
$8.2M
$7.3M
$7.5M
Stockholders' equity
-$8.7M
-$6.9M
-$5.9M
-$4.0M
-$3.7M
Cash and investments
$35,471
$313,396
$706,740
—
—
Total debt
$260,647
$285,273
$309,938
$332,573
$354,763

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Other events
Sep 8, 2026 Sep 8, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 4, 2026 Aug 31, 2026
8-K Current report
Other events
Aug 17, 2026 Aug 17, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Officer or director change, Other events
Aug 14, 2026 Aug 13, 2026
8-K Current report
Officer or director change
Jun 4, 2026 Jun 1, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.